<p>Our FX strategists discussed more short-term scenarios, with arguably 3 out of 4 discussions being helpful with navigating a challenging environment.</p>
Blogs
Artificial Disc Replacement Market Expected to Reach US$ 2.37 Billion by 2034: Fact.MR Study
<p>Constant Technological Advancements Boosting Efficiency of Artificial Disc Replacement Interventions Rockville , Dec. 17, 2023 (GLOBE NEWSWIRE) — According to Fact.MR, a market research and competitive intelligence provider, the global artificial disc replacement market is pegged at US$ 805.5 million for 2024 and is predicted to expa
Illumina to sell cancer-test maker Grail after latest antitrust ruling
<p>Illumina Inc. said Sunday it will sell its Grail unit, after a federal appeals court on Friday found the $7.1 billion acquisition in 2021 to be anticompetitive. Read Full Story</p> <p>The post <a href="https://forextv.com/market-news/illumina-to-sell-cancer-test-maker-grail-after-latest-antitrust-ruling/">Illumi
TUESDAY INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Farfetch Limited Investors with Substantial Losses Have Opportunity to Lead Case – FTCH
<p>SAN DIEGO, Dec. 17, 2023 (GLOBE NEWSWIRE) — Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Farfetch Limited (NYSE: FTCH) securities between March 9, 2023 and August 17, 2023, both dates inclusive (the “Class Period”), have until this upcoming Tuesday, December 19, 2023 to seek appointment as lead plai
TOP RANKED ROSEN LAW FIRM Encourages National Instruments Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – NATI
<p>NEW YORK, Dec. 17, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds sellers of common stock of National Instruments Corporation (NASDAQ: NATI) between May 25, 2022 and January 17, 2023, both dates inclusive (the “Class Period”), of the important January 29, 2024 lead plaintiff deadline. SO WHAT:
Tagatose Market to Surpass US$ 289.2 Million at 6% CAGR by 2034: Fact.MR Report
<p>Rising Consumer Preference for Organic and Natural Ingredients Stimulating Demand for Tagatose Rockville, Dec. 17, 2023 (GLOBE NEWSWIRE) — The global Tagatose Market is estimated at a value of US$ 162.1 million in 2024, as per a new study published by Fact.MR, a market research and competitive intelligence provider. Worldwide dem
NATIONALLY RANKED ROSEN LAW FIRM Encourages LivePerson, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – LPSN
<p>NEW YORK, Dec. 17, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of LivePerson, Inc. (NASDAQ: LPSN) between May 10, 2022 and March 16, 2023, both dates inclusive (the “Class Period”), of the important January 30, 2024 lead plaintiff deadline. SO WHAT: If you purchased
My wife and I are separating. I provided the down payment, and paid the mortgage on our home. Will I be allowed to keep it if we divorce?
<p>“I am concerned she may be entitled to half of the property, although I have been making all the mortgage payments.” Read Full Story</p> <p>The post <a href="https://forextv.com/market-news/my-wife-and-i-are-separating-i-provided-the-down-payment-and-paid-the-mortgage-on-our-home-will-i-be-allowed-to-keep-it
I co-own a home with my sister and her husband. They’re getting divorced and he wants his share of the property. What can I do?
<p>“All rental income was deposited into my bank account, but they claimed the property on their taxes.” Read Full Story</p> <p>The post <a href="https://forextv.com/market-news/i-co-own-a-home-with-my-sister-and-her-husband-theyre-getting-divorced-and-he-wants-his-share-of-the-property-what-can-i-do/">
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Veradigm Inc. f/k/a Allscripts Healthcare Solutions, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MDRX
<p>NEW YORK, Dec. 17, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Veradigm Inc. f/k/a Allscripts Healthcare Solutions, Inc. (NASDAQ: MDRX) between February 26, 2021 and June 13, 2023, both dates inclusive (the “Class Period”), of the important January 22, 2024